Locations:
Search IconSearch
August 20, 2015/Neurosciences

Treating Essential Tremor

Common disorder raises uncommon issues for physicians

ET_690x380

Chances are good that you’ll encounter essential tremor (ET) in your primary care practice. It’s the most common movement disorder, affecting all age ranges and as many as 6 to 9 percent of people 60 and older according to prevalence studies.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

But due to embarrassment, fear or normalization, your patients may not volunteer that they’re having problems. That means you’ll have to rely more on observational and interview skills to uncover what’s going on and begin the diagnostic and treatment process, says Cleveland Clinic neurologist Michal Gostkowski, DO. Some advice on how to proceed:

Initial signs

ET involuntary movements most often involve the hands and occur during action, in contrast to Parkinson disease (PD) tremors, which occur at rest. ET patients may try to mask or hide their shaking, so Dr. Gostkowski watches their hands when they’re distracted and listens to vocal tremors, another distinctive ET symptom. He also asks if their activities have changed. ET patients may stop socializing or discontinue hobbies that are affected by their tremors. Those restrictions, in turn, may trigger depression, another indicator to watch for. Also, since alcohol can temporarily dampen ET tremors, sufferers may be vulnerable to alcohol overuse or addiction.

Other diagnostic aids

Though ET has its own complications, your patient’s biggest early concern may be that his or her tremors result from PD. A neurologist can make the definitive diagnosis, but for reassurance’s sake, some simple tests in your office — handwriting and water-pouring ability can help differentiate ET from PD. ET patients’ handwriting is large and scratchy-looking, while PD patients’ rigidity results in smaller and smaller printing (a condition called micrographia). ET patients also have trouble pouring water from one cup to another, a task that PD patients execute without spills because their tremors occur at rest.

Patient questions

Your patients likely will ask what caused their ET and what course their disease will take. Though ET clearly has a strong genetic component, no ET-linked genes have been identified so far, and it is likely that some as-yet unknown environmental cofactors are involved. Tremors tend to become more severe as patients age, with some association between age of ET onset and how quickly ET progresses. Older-onset patients have a faster rate of progression.

Medical treatment

Unfortunately, medications are only modestly effective at reducing ET tremors. The beta-blocker propranolol and the anti-seizure drug primidone are the most studied and seemingly the more beneficial, but each lessens tremor in about half of ET patients. Other ET medications include benzodiazepines and anticholinergics, which should be used cautiously in older patients.

Surgery

Deep brain stimulation (DBS) of the thalamus has shown good results in ET. “It’s a very viable option,” Dr. Gostkowski says. “We expect 70 percent to 80 percent improvement in the tremor in about 90 percent of patients,” with minimal side effects. ET patients and their physicians should consider DBS when tremors begin to impair daily living activities.

Advertisement

Related Articles

woman preparing for sleep study with healthcare provider
Study Illuminates Challenges of Multiple Sleep Latency Testing in Patients on REM-Suppressing Antidepressants

Nearly 80% of patients didn’t follow washout protocol, raising risk of misdiagnosis

brain vessels in primary angiitis of the CNS
Differentiating Primary CNS Angiitis From Atherosclerosis as a Cause of Stroke

Combining quantitative vessel wall MRI metrics, CSF abnormalities and neurologic symptoms can be highly predictive

older man being pushed in wheelchair
Study Documents Racial and Ethnic Gaps in Post-Acute Care for Stroke

Uninsured Hispanics least likely to be discharged to facility-based rehab or home healthcare

Dr. Amy Kunchok against decorative background
July 16, 2024/Neurosciences/Podcast
What to Know About Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) (Podcast)

It’s time to get familiar with this emerging demyelinating disorder

older man taking cognitive test on computer tablet
Self-Administered Screening Tool for Cognitive Dysfunction Rolled Out in Primary Care Clinics

Cleveland Clinic Cognitive Battery identifies at-risk patients during Medicare annual visits

receptor activity for myasthenia gravis medications
July 3, 2024/Neurosciences/Podcast
Myasthenia Gravis: Unmet Needs and Efforts to Address Them (Podcast)

An overview of associated antibodies, therapies for antibody-positive disease and the outlook for atypical forms of MG

woman on stationary exercise cycle
July 1, 2024/Neurosciences/PM&R
New Trial to Assess Forced Exercise for Subacute Stroke Recovery

Research to test clinical efficacy and cost-effectiveness versus standard-of-care rehab

vertebral hemangioma on MRI
Spine Stereotactic Radiosurgery for Symptomatic Vertebral Hemangiomas With Epidural Extension

Safety and efficacy demonstrated in largest case series reported to date

Ad